Feuerlein, W.: Alkoholismus als Krankheit. Herz 21, pp. 213 - 216 (1996)

Feuerlein, W.; Küfner, H.: The amount of treatment and the outcome. Comment on Finney et al: The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderaters of setting effects. Addiction 91, pp. 1807 - 1808 (1996)

Fichter, M. M.; Koniarczyk, M.; Greifenhagen, A.; Koegel, P.; Quadflieg, N.; Wittchen, H.-U.; Wölz, J.: Mental illness in a representative sample of homeless men in Munich, Germany. European Archives of Psychiatry and Clinical Neuroscience 246, pp. 185 - 196 (1996)

Gillardon, F.; Skutella, T.; Uhlmann, E.; Holsboer, F.; Zimmermann, M.; Behl, C.: Activation of c-Fos contributes to amyloid β peptide-induced neurotoxicity. Brain Research 706, pp. 169 - 172 (1996)

Grön, G.: Cognitive slowing in patients with acquired brain damage: An experimental approach. Journal of Clinical and Experimental Neuropsychology 18, pp. 406 - 415 (1996)

Gutzmann, H.; Krüger, H.; Richert, A.; Mombour, W.: Organic Mental Disorders (F0).Results from the ICD-10 field trial of the diagnostic criteria for research in German speaking countries. Psychopathology 5, pp. 267 - 273 (1996)

Hartmann, A.; Heuser, I.: Neurosteroide - Grundlagen, Anxiolyse und klinische Anwendungsmöglichkeiten. Fortschritte der Neurologie, Psychiatrie 64, pp. 444 - 451 (1996)

Hassan, A. H. S.; Rosenstiel, P. v.; Patchev, V. K.; Holsboer, F.; Almeida, O. F. X.: Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Experimental Neurology 140, pp. 43 - 52 (1996)

Hatzinger, M.; Reul, J. M. H. M.; Landgraf, R.; Holsboer, F.: Hypothalamic-pituitary-adrenocortical axis changes in aging rats as revealed by the combined dexamethasone/corticotropin-releasing hormone test paradigm. Neuroendocrinology 64, pp. 349 - 356 (1996)

Hauser, C. A. E.; Wetzel, C. R.; Rupprecht, R.; Holsboer, F.: Allopregnanolone acts as an inhibitory modulator on α₁-and α₆-containing GABA_Α receptors. Biochemical and Biophysical Research Communications 219, pp. 531 - 536 (1996)

Hermann, B.; Wetzel, C. R.; Pestel, E.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Functional antagonistic properties of clozapine at the 5-HT₃ receptor. Biochemical and Biophysical Research Communications 225, pp. 957 - 960 (1996)

Heuser, I.: Gedächtnisstörungen. Der Internist 37, pp. 1189 - 1202 (1996)

Heuser, I.; Schweiger, U.; Gotthardt, U.; Schmider, J.; Lammers, C. H.; Dettling, M.; Holsboer, F.: Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal controls. American Journal of Psychiatry 153, pp. 93 - 99 (1996)

Hinze-Selch, D.; Becker, E.; Stein, G.; Schreiber, W.; Pollmächer, T.: Parotitis and increased stimulation index in lymphocyte transformation test in a clozapine-treated patient. American Journal of Psychiatry 153, p. 840 - 840 (1996)

Hinze-Selch, D.; Mullington, J.; Orth, A.; Lauer, C.; Pollmächer, T.: Effects of clozapine on sleep: a longitudinal study. Biological Psychiatry 4, pp. 1 - 7 (1996)

Hinze-Selch, D.; Mullington, J.; Pollmächer, T.: Clozapin, Zytokine, Fieber und Schlaf. Wiener Medizinische Wochenschrift 146, pp. 311 - 313 (1996)

Holsboer, F.: Nervenheilkunde als angewandte Neurowissenschaft. Jatros Neurologie 1, pp. 16 - 25 (1996)

Holsboer, F.; Barden, N.: Antidepressants and HPA regulation. Endocrine Reviews 17, pp. 187 - 205 (1996)

Kendler, K. S.; Zerbin-Rüdin, E.: Abstract and review of "Studien über Vererbung und Entstehung geistiger Störungen. I Zur Vererbung und Neuentstehung der Dementia praecox". Americsn Journal of Medical Genetics 67, pp. 338 - 342 (1996)

Kendler, K. S.; Zerbin-Rüdin, E.: Abstract and review of "Zur Erbpathologie der Schizophrenie". American Journal of Medical Genetics 67, pp. 343 - 346 (1996)